The overall in-hospital mortality was 31% (504/1 607) and was marginally higher among patients treated with colistin-sparing therapy compared to patients treated with colistin-based therapy (32% [352/1 086] vs 29% [152/521], p =0.18) however, the difference did not reach statistical significance.
← all excerpts
The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study
1
—
—